Analyze Diet
Journal of veterinary pharmacology and therapeutics1997; 20(5); 396-401; doi: 10.1046/j.1365-2885.1997.00089.x

Development and characterization of an equine behaviour chamber and the effects of amitraz and detomidine on spontaneous locomotor activity.

Abstract: This report describes the development of a behaviour chamber and the validation of the chamber of measure locomotor activity of a horse. Locomotor activity was detected by four Mini-beam sensors and recorded on a data logger every 5 min for 22 h. Horses were more active during daytime than in the evening, which was at least partially related to human activity in their surroundings. To validate the ability of the chambers to detect changes in activity, fentanyl citrate and xylazine HCl, agents well-characterized as a stimulant and a depressant, respectively, were administered to five horses. Fentanyl citrate (0.016 mg/kg) significantly increased locomotor activity which persisted for 30 min. Xylazine HCl (1 mg/kg) significantly reduced locomotor activity for 90 min. Amitraz produced a dose-dependent decrease in locomotor activity, lasting 75 min for the 0.05 mg/kg dose, 120 min for the 0.10 mg/kg dose, and 180 min for the 0.15 mg/kg dose. In a separate experiment, yohimbine administration immediately reversed the sedative effect of amitraz. This suggests there is a similarity in the mode of action of amitraz, xylazine and detomidine, as yohimbine acts primarily by blocking central alpha 2 -adrenoceptors that are stimulated by agents like xylazine. There was also a significant decrease in locomotor activity following injection of detomidine (0.02, 0.04 and 0.08 mg/kg) for 1.5, 3.5 and 5.0 h, respectively. The locomotor chamber is a useful, sensitive and highly reproducible tool for measuring spontaneous locomotor activity in the horse, which allows investigators to determine an agent's average time of onset, duration and intensity of effect on movement.
Publication Date: 1997-11-14 PubMed ID: 9350261DOI: 10.1046/j.1365-2885.1997.00089.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research concerns the design and testing of a behavior chamber to measure horse locomotion, as well as investigating the effects of the drugs amitraz and detomidine on such activity.

Development of a Behaviour Chamber for Horses

  • The researchers developed a behaviour chamber equipped with four Mini-beam sensors to accurately monitor and record a horse’s locomotor activity.
  • The data collected was logged every five minutes over a 22-hour period.
  • Findings showed horses were more active during the daytime, a pattern believed to be partially influenced by human activities around them.

Testing and Validation

  • For validation, the researchers administered fentanyl citrate and xylazine HCl, known stimulant and depressant agents respectively, to five horses.
  • The results showed that fentanyl citrate, at 0.016 mg/kg, significantly increased locomotor activity, lasting for about 30 minutes.
  • In contrast, xylazine HCl at 1 mg/kg brought about a significant decrease in locomotor activity lasting for 90 minutes.

The Effects of Amitraz

  • Amitraz produced a dose-dependent decrease in locomotor activity in the horses.
  • This effect persisted for 75 minutes at a dose of 0.05 mg/kg, 120 minutes at 0.10 mg/kg, and 180 minutes at the 0.15 mg/kg dose.
  • In a separate experiment, yohimbine was administered, which reversed the sedative effects of amitraz, providing insights on the similarity in the mode of action of amitraz, xylazine, and detomidine.

The Effects of Detomidine

  • The study also showed that detomidine caused a significant decrease in locomotor activity in horses over varying periods of time depending on the dose given.
  • That is, an injection of detomidine at 0.02 mg/kg reduced activity levels for 1.5 hours, at 0.04 mg/kg for 3.5 hours, and at 0.08 mg/kg for 5.0 hours.

Significance of the Study

  • Overall, the study shows the developed locomotor chamber for horses to be a sensitive and highly reproducible tool for the measurement of spontaneous locomotor activity.
  • It also provides researchers a means to determine the average onset, duration, and intensity of the effect of different substances on horse movement.

Cite This Article

APA
Harkins JD, Queiroz-Neto A, Mundy GD, West D, Tobin T. (1997). Development and characterization of an equine behaviour chamber and the effects of amitraz and detomidine on spontaneous locomotor activity. J Vet Pharmacol Ther, 20(5), 396-401. https://doi.org/10.1046/j.1365-2885.1997.00089.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 20
Issue: 5
Pages: 396-401

Researcher Affiliations

Harkins, J D
  • Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington 40506, USA.
Queiroz-Neto, A
    Mundy, G D
      West, D
        Tobin, T

          MeSH Terms

          • Animals
          • Circadian Rhythm
          • Dose-Response Relationship, Drug
          • Fentanyl / pharmacology
          • Horses / physiology
          • Hypnotics and Sedatives / pharmacology
          • Imidazoles / pharmacology
          • Injections, Intravenous / veterinary
          • Insect Repellents / pharmacology
          • Locomotion
          • Male
          • Motor Activity / drug effects
          • Narcotics / pharmacology
          • Toluidines / pharmacology
          • Xylazine / pharmacology

          Citations

          This article has been cited 2 times.
          1. Digranes N, Haga HA, Nordgreen J. High and Hyper: Fentanyl Induces Psychomotor Side-Effects in Healthy Pigs.. Animals (Basel) 2023 May 17;13(10).
            doi: 10.3390/ani13101671pubmed: 37238100google scholar: lookup
          2. Cruz FS, Carregaro AB, Machado M, Antonow RR. Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses.. Can J Vet Res 2011 Jan;75(1):35-41.
            pubmed: 21461193